BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35304760)

  • 21. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
    Salaroglio IC; Abate C; Rolando B; Battaglia L; Gazzano E; Colombino E; Costamagna C; Annovazzi L; Mellai M; Berardi F; Capucchio MT; Schiffer D; Riganti C
    Mol Pharm; 2019 Aug; 16(8):3361-3373. PubMed ID: 31265310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex.
    Choo XY; McInnes LE; Grubman A; Wasielewska JM; Belaya I; Burrows E; Quek H; Martín JC; Loppi S; Sorvari A; Rait D; Powell A; Duncan C; Liddell JR; Tanila H; Polo JM; Malm T; Kanninen KM; Donnelly PS; White AR
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD.
    Pan J; He R; Huo Q; Shi Y; Zhao L
    Neurochem Res; 2020 Sep; 45(9):2161-2172. PubMed ID: 32583212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
    Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
    Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial effects of copper(II) bis(thiosemicarbazonato) complexes provide new insight into their biochemical mode of action.
    Djoko KY; Paterson BM; Donnelly PS; McEwan AG
    Metallomics; 2014 Apr; 6(4):854-63. PubMed ID: 24435165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing intracellular bioavailable copper selectively targets prostate cancer cells.
    Cater MA; Pearson HB; Wolyniec K; Klaver P; Bilandzic M; Paterson BM; Bush AI; Humbert PO; La Fontaine S; Donnelly PS; Haupt Y
    ACS Chem Biol; 2013 Jul; 8(7):1621-31. PubMed ID: 23656859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.
    Durk MR; Chan GN; Campos CR; Peart JC; Chow EC; Lee E; Cannon RE; Bendayan R; Miller DS; Pang KS
    J Neurochem; 2012 Dec; 123(6):944-53. PubMed ID: 23035695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of an In-Cell Western for Quantifying P-Glycoprotein Expression in Human Brain Microvascular Endothelial (hCMEC/D3) Cells.
    McInerney MP; Pan Y; Short JL; Nicolazzo JA
    J Pharm Sci; 2017 Sep; 106(9):2614-2624. PubMed ID: 28065764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.
    Emmert D; Campos CR; Ward D; Lu P; Namanja HA; Bohn K; Miller DS; Sharom FJ; Chmielewski J; Hrycyna CA
    ACS Chem Neurosci; 2014 Apr; 5(4):305-17. PubMed ID: 24483607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells.
    Chan GN; Patel R; Cummins CL; Bendayan R
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4481-8. PubMed ID: 23836171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells.
    Lim JC; Kania KD; Wijesuriya H; Chawla S; Sethi JK; Pulaski L; Romero IA; Couraud PO; Weksler BB; Hladky SB; Barrand MA
    J Neurochem; 2008 Aug; 106(4):1855-65. PubMed ID: 18624906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular localization of a fluorescent derivative of CuII(atsm) offers insight into the neuroprotective action of CuII(atsm).
    Price KA; Crouch PJ; Lim S; Paterson BM; Liddell JR; Donnelly PS; White AR
    Metallomics; 2011 Dec; 3(12):1280-90. PubMed ID: 21927768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of P-Glycoprotein in the Brain.
    Chai AB; Callaghan R; Gelissen IC
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative Release of Copper from Pharmacologic Copper Bis(thiosemicarbazonato) Compounds.
    Sirois JJ; Padgitt-Cobb L; Gallegos MA; Beckman JS; Beaudry CM; Hurst JK
    Inorg Chem; 2018 Aug; 57(15):8923-8932. PubMed ID: 29979041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function.
    Goutal S; Novell A; Leterrier S; Breuil L; Selingue E; Gerstenmayer M; Marie S; Saubaméa B; Caillé F; Langer O; Truillet C; Larrat B; Tournier N
    J Control Release; 2023 Sep; 361():483-492. PubMed ID: 37562557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.
    Qosa H; Abuznait AH; Hill RA; Kaddoumi A
    J Alzheimers Dis; 2012; 31(1):151-65. PubMed ID: 22504320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
    Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.